EMA Authorised: Trizivir (abacavir (as sulfate);lamivudine;zidovudine) — ViiV Healthcare BV

View source ↗

Summary

EMA has authorised Trizivir, a fixed-dose combination of abacavir (as sulfate), lamivudine, and zidovudine, for HIV infections, under ViiV Healthcare BV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Trizivir

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare BV. Decision date: 15/01/2026